Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Goiter × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Pain, Postoperative 8 Prostatic Neoplasms 4 Pain 4 Agnosia 4 Stomach Neoplasms 3 Lung Neoplasms 3 Postoperative Complications 2 Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Sleep Deprivation 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Ganglion Cysts 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Emergence Delirium 1 Chronic Pain 1

Interventions

Bupivacaine 2 acetaminophen, codeine drug combination 1 Triiodothyronine 1 Tramadol 1 Thyroxine 1 Thyroidectomy 1 Ropivacaine 1 Negative-Pressure Wound Therapy 1 Ketorolac 1 Indocyanine Green 1 Hyaluronic Acid 1 Glucose 1 Epinephrine 1 Dexmedetomidine 1 Capsules 1 Calcium Carbonate 1 Calcitriol 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02112370 2017-08-04

REBT

Seoul National University Hospital

Phase 3 Completed

148 enrolled 17 charts

Goiter, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡